EUVIMEDEUVIMED entdecken
Crossref

The significance of valosin-containing protein (VCP)/p97 expression in laryngeal carcinomas

Inga M.C. Seuthe, Hanna C. Hunsicker-Biederbeck, Eric Ehrke-Schulz, Goar Agabekian, Markus Ruwe, Jasmin Drusenheimer, Jonas Park

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S237

DOI: 10.1055/s-0044-1784778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Inga M.C. Seuthe und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Several studies have shown that valosin-containing protein (VCP)/p97 is associated with anti-apoptotic function and tumor metastasis via activation of the nuclear factor-κB (NF-κB) pathway. Initial studies indicated that the expression of VCP in oral cavity and oropharyngeal carcinomas has prognostic significance. In addition, VCP inhibitors were investigated in initial experimental studies on squamous cell carcinomas of the esophagus. Material and methods 50 patients with laryngeal carcinoma were included. 48% of the patients had advanced tumors (stage 3 and 4 according to UICC). The immunohistochemical examination of the tissue samples obtained during the tumor biopsy was performed. The clinical data were correlated with the VCP expression pattern.

Results

A high VCP staining intensity was found in 66% of the tumor samples. VCP expression did not affect recurrence-free survival or overall survival. There was no significant correlation of VCP expression with tumor stage.

Discussion

In laryngeal carcinomas, the prognostic significance found in oral cavity and oropharyngeal carcinomas cannot be confirmed. However, VCP expression is high in laryngeal carcinomas. Experimental studies on the efficacy of VCP inhibitors in laryngeal carcinomas should be considered, as drugs with an anti-apoptotic effect, such as IAP antagonists, are already showing promising initial clinical results in head and neck tumor patients. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Seuthe, I. M., Hunsicker-Biederbeck, H. C., Ehrke-Schulz, E., Agabekian, G., Ruwe, M., Drusenheimer, J., & Park, J. (2024). The significance of valosin-containing protein (VCP)/p97 expression in laryngeal carcinomas. Laryngo-Rhino-Otologie, 103(S 02 S 02), S237. https://doi.org/10.1055/s-0044-1784778

Vancouver

Seuthe IM, Hunsicker-Biederbeck HC, Ehrke-Schulz E, Agabekian G, Ruwe M, Drusenheimer J, et al. The significance of valosin-containing protein (VCP)/p97 expression in laryngeal carcinomas. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S237. doi:10.1055/s-0044-1784778

BibTeX
@article{Seuthe2024,
  author = {Seuthe, Inga M.C. and Hunsicker-Biederbeck, Hanna C. and Ehrke-Schulz, Eric and Agabekian, Goar and Ruwe, Markus and Drusenheimer, Jasmin and Park, Jonas},
  title = {The significance of valosin-containing protein (VCP)/p97 expression in laryngeal carcinomas},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S237},
  doi = {10.1055/s-0044-1784778}
}
Kostenlos starten →